scholarly journals EP-2190 MVCT in pediatric craniospinal radiotherapy

2019 ◽  
Vol 133 ◽  
pp. S1208
Author(s):  
F. Ferraro ◽  
A. Lastrucci ◽  
Y. Wandael ◽  
C. Galeotti ◽  
M. Vernaleone ◽  
...  
Keyword(s):  
Craniospinal Radiotherapy

scholarly journals O08 * HAEMATOLOGICAL TOXICITIES IN CRANIOSPINAL RADIOTHERAPY: A 10-YEAR REVIEW

2014 ◽  
Vol 16 (suppl 6) ◽  
pp. vi14-vi14
Author(s):  
K. Chua ◽  
Y. C. Chang ◽  
M. N. Gaze ◽  
S. C. Short ◽  
N. Fersht
Keyword(s):  
Craniospinal Radiotherapy

scholarly journals Postoperative craniospinal radiotherapy of medulloblastoma in children and young adults

2003 ◽  
Vol 131 (5-6) ◽  
pp. 226-231
Author(s):  
Ivana Golubicic ◽  
Jelena Bokun ◽  
Marina Nikitovic ◽  
Jasmina Mladenovic ◽  
Milan Saric ◽  
...  
Keyword(s):  
High Risk ◽  
Brain Stem ◽  
Wilcoxon Test ◽  
Time Interval ◽  
Tumor Removal ◽  
Shunt Placement ◽  
Craniospinal Radiotherapy ◽  
Number Of Patients ◽  
Significant Difference

PURPOSE The aim of this study was: 1. to evaluate treatment results of combined therapy (surgery, postoperative craniospinal radiotherapy with or without chemotherapy) and 2. to assess factors affecting prognosis (extend of tumor removal, involvement of the brain stem, extent of disease postoperative meningitis, shunt placement, age, sex and time interval from surgery to start of postoperative radiotherapy). PATIENTS AND METHODS During the period 1986-1996, 78 patients with medulloblastoma, aged 1-22 years (median 8.6 years), were treated with combined modality therapy and 72 of them were evaluable for the study end-points. Entry criteria were histologically proven diagnosis, age under 22 years, and no history of previous malignant disease. The main characteristics of the group are shown in Table 1. Twenty-nine patients (37.2%) have total, 8 (10.3%) near total and 41 (52.5%) partial removal. Seventy-two of 78 patients were treated with curative intent and received postoperative craniospinal irradiation. Radiotherapy started 13-285 days after surgery (median 36 days). Only 13 patients started radiotherapy after 60 days following surgery. Adjuvant chemotherapy was applied in 63 (80.7%) patients. The majority of them (46 73%) received chemotherapy with CCNU and Vincristine. The survival rates were calculated with the Kaplan-Meier method and the differences in survival were analyzed using the Wilcoxon test and log-rank test. RESULTS The follow-up period ranged from 1-12 years (median 3 years). Five-year overall survival (OS) was 51% and disease-free survival (DFS) 47% (Graph 1). During follow-up 32 relapses occurred. Patients having no brain stem infiltration had significantly better survival (p=0.0023) (Graph 2). Patients with positive myelographic findings had significantly poorer survival compared to dose with negative myelographic findings (p=0.0116). Significantly poorer survival was found in patients with meningitis developing in the postoperative period, with no patient living longer than two years (p=0.0134) (Graph 3). By analysis of OS and DFS in relation to presence of the malignant cells in liquor, statistically significant difference, i. e. positive CSF cytology was not obtained, which was of statistical importance for survival (p=0.8207). Neither shunt placement nor shunt type showed any impact on survival (p=0.5307 and 0.7119, respectively). Children younger than three years had significantly poorer survival compared to those older than 16 years (p=0.0473). Although there was a better survival rate in females than in males this was not statistically significant (p=0.2386).The analysis results of treatment showed that significantly better survival occurred in patients in whom total or subtotal tumor removal was possible (p=0.0022) (Graph 4). Patients who started radiotherapy within two months after surgery have better survival, but again this was not statistically significant, probably due to the small number of patients receiving delayed radiotherapy (p=0.2231)(Graph5). CONCLUSION Based on this factors standard and high risk group could be defined. Combined chemotherapy should to be investigated particularly for high risk subgroup. Future research should be done to define new therapeutic modalities (gene therapy, compounds active in tumor antiangiogenesis etc).

Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors

2012 ◽  
Vol 110 (2) ◽  
pp. 287-291 ◽  
Author(s):  
Cynthia J. Campen ◽  
Joanna Dearlove ◽  
Sonia Partap ◽  
Patricia Murphy ◽  
Iris C. Gibbs ◽  
...  
Keyword(s):  
High Risk ◽  
Brain Tumors ◽  
Craniospinal Radiotherapy ◽  
Embryonal Brain

Craniospinal Radiotherapy for Medulloblastoma in a Man with Severe Kyphoscoliosis

2001 ◽  
Vol 13 (2) ◽  
pp. 117-119
Author(s):  
B.K. Yap ◽  
B. Magee ◽  
S.E. Vollans
Keyword(s):  
Craniospinal Radiotherapy

Secondary parkinsonism: An unusual late complication of craniospinal radiotherapy given to a 16-month child

2002 ◽  
Vol 40 (2) ◽  
pp. 132-134 ◽  
Author(s):  
J.A. Skiming ◽  
H.P. McDowell ◽  
N. Wright ◽  
P. May
Keyword(s):  
Late Complication ◽  
Craniospinal Radiotherapy

Medullablastomas And Ependymomas Treated With Craniospinal Radiotherapy

1991 ◽  
Vol 1 (2) ◽  
pp. 133-136
Author(s):  
Ayfer Haydaroğlu ◽  
Arif Aras ◽  
Serdar Özkök ◽  
Senay Öztop ◽  
Saffet Mutluer
Keyword(s):  
Craniospinal Radiotherapy
Sign in / Sign up

Export Citation Format

Share Document